Table of Contents
<< Previous Issue | Apr 2019 (Vol: 2019, Issue: 4) | Next Issue >> |
- Section: Licensing
-
AstraZeneca Partners Again with Daiichi Sankyo for its ADC Cancer Treatment
- Section: Mergers & Acquisitions
-
Novartis Boosts Immunology Investment with IFM Tre Acquisition
- Section: Opinion & Analysis
-
IQVIA Pharma Deals: Review of 2018
- Section: Research & Development
-
Lilly Affirms Immunology Interest with US$605 M ImmuNext Deal
-
Regeneron Forms Second RNAi Partnership with Alnylam
-
Gilead Looks to Machine Learning with insitro NASH Collaboration